These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 34254844)
1. Chemical Modifications of the Capsid for Redirecting and Improving the Efficacy of Adeno-Associated Virus Vectors. Lam AK; Frabutt D; Li L; Xiao W Hum Gene Ther; 2021 Dec; 32(23-24):1433-1438. PubMed ID: 34254844 [TBL] [Abstract][Full Text] [Related]
2. Chemical approaches to probe and engineer AAV vectors. Pham Q; Glicksman J; Chatterjee A Nanoscale; 2024 Jul; 16(29):13820-13833. PubMed ID: 38978480 [TBL] [Abstract][Full Text] [Related]
3. Genetic Engineering of AAV Capsid Gene for Gene Therapy Application. Liu Y; Zhang X; Yang L Curr Gene Ther; 2020; 20(5):321-332. PubMed ID: 32998676 [TBL] [Abstract][Full Text] [Related]
10. Coevolution of Adeno-associated Virus Capsid Antigenicity and Tropism through a Structure-Guided Approach. Havlik LP; Simon KE; Smith JK; Klinc KA; Tse LV; Oh DK; Fanous MM; Meganck RM; Mietzsch M; Kleinschmidt J; Agbandje-McKenna M; Asokan A J Virol; 2020 Sep; 94(19):. PubMed ID: 32669336 [TBL] [Abstract][Full Text] [Related]
11. Chemical modification of AAV9 capsid with N-ethyl maleimide alters vector tissue tropism. Mulcrone PL; Lam AK; Frabutt D; Zhang J; Chrzanowski M; Herzog RW; Xiao W Sci Rep; 2023 May; 13(1):8436. PubMed ID: 37231038 [TBL] [Abstract][Full Text] [Related]
12. Vector Affinity and Receptor Distribution Define Tissue-Specific Targeting in an Engineered AAV Capsid. Martino RA; Wang Q; Xu H; Hu G; Bell P; Arroyo EJ; Sims JJ; Wilson JM J Virol; 2023 Jun; 97(6):e0017423. PubMed ID: 37199615 [TBL] [Abstract][Full Text] [Related]
14. Post-translational modifications in capsid proteins of recombinant adeno-associated virus (AAV) 1-rh10 serotypes. Mary B; Maurya S; Arumugam S; Kumar V; Jayandharan GR FEBS J; 2019 Dec; 286(24):4964-4981. PubMed ID: 31330090 [TBL] [Abstract][Full Text] [Related]
15. Tracking Adeno-Associated Virus Capsid Evolution by High-Throughput Sequencing. de Alencastro G; Pekrun K; Valdmanis P; Tiffany M; Xu J; Kay MA Hum Gene Ther; 2020 May; 31(9-10):553-564. PubMed ID: 32024384 [TBL] [Abstract][Full Text] [Related]
16. Context-Specific Function of the Engineered Peptide Domain of PHP.B. Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767 [TBL] [Abstract][Full Text] [Related]
17. Site-Specific Post-translational Surface Modification of Adeno-Associated Virus Vectors Using Leucine Zippers. Thadani NN; Yang J; Moyo B; Lee CM; Chen MY; Bao G; Suh J ACS Synth Biol; 2020 Mar; 9(3):461-467. PubMed ID: 32068391 [TBL] [Abstract][Full Text] [Related]
18. Adeno-Associated Virus Vector Design-Moving the Adeno-Associated Virus to a Bioengineered Therapeutic Nanoparticle. Jäschke N; Büning H Hematol Oncol Clin North Am; 2022 Aug; 36(4):667-685. PubMed ID: 35778330 [TBL] [Abstract][Full Text] [Related]
19. Improving clinical efficacy of adeno associated vectors by rational capsid bioengineering. Sen D J Biomed Sci; 2014 Nov; 21(1):103. PubMed ID: 25425174 [TBL] [Abstract][Full Text] [Related]